201 related articles for article (PubMed ID: 28989100)
1. Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.
Fabbri C; Corponi F; Albani D; Raimondi I; Forloni G; Schruers K; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Cristalli CP; Mantovani V; Mendlewicz J; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():203-210. PubMed ID: 28989100
[TBL] [Abstract][Full Text] [Related]
2. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples.
Fabbri C; Kasper S; Kautzky A; Bartova L; Dold M; Zohar J; Souery D; Montgomery S; Albani D; Raimondi I; Dikeos D; Rujescu D; Uher R; Lewis CM; Mendlewicz J; Serretti A
Br J Psychiatry; 2019 Jan; 214(1):36-41. PubMed ID: 30468137
[TBL] [Abstract][Full Text] [Related]
4. ANK3 and CACNA1C--missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples.
Kloiber S; Czamara D; Karbalai N; Müller-Myhsok B; Hennings J; Holsboer F; Lucae S
J Psychiatr Res; 2012 Aug; 46(8):973-9. PubMed ID: 22647524
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.
Horstmann S; Lucae S; Menke A; Hennings JM; Ising M; Roeske D; Müller-Myhsok B; Holsboer F; Binder EB
Neuropsychopharmacology; 2010 Feb; 35(3):727-40. PubMed ID: 19924111
[TBL] [Abstract][Full Text] [Related]
6. Lack of association of FKBP5 SNPs and haplotypes with susceptibility and treatment response phenotypes in Han Chinese with major depressive disorder: A pilot case-control study (STROBE).
Yang C; Li S; Ma Y; Chen B; Li M; Bosker FJ; Li J; Nolte IM
Medicine (Baltimore); 2021 Sep; 100(36):e26983. PubMed ID: 34516490
[TBL] [Abstract][Full Text] [Related]
7. The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression.
Stamm TJ; Rampp C; Wiethoff K; Stingl J; Mössner R; O Malley G; Ricken R; Seemüller F; Keck M; Fisher R; Gaebel W; Maier W; Möller HJ; Bauer M; Adli M
J Psychopharmacol; 2016 Jan; 30(1):40-7. PubMed ID: 26645208
[TBL] [Abstract][Full Text] [Related]
8. The role of GRIK4 gene in treatment-resistant depression.
Milanesi E; Bonvicini C; Congiu C; Bortolomasi M; Gainelli G; Gennarelli M; Minelli A
Genet Res (Camb); 2015 Jul; 97():e14. PubMed ID: 26139080
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway.
Cocchi E; Fabbri C; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU; Serretti A
BMC Psychiatry; 2016 Apr; 16():106. PubMed ID: 27091189
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants associated with psychotic symptoms across psychiatric disorders.
Calabrò M; Porcelli S; Crisafulli C; Albani D; Kasper S; Zohar J; Souery D; Montgomery S; Mantovani V; Mendlewicz J; Bonassi S; Vieta E; Frustaci A; Ducci G; Landi S; Boccia S; Bellomo A; Di Nicola M; Janiri L; Colombo R; Benedetti F; Mandelli L; Fabbri C; Serretti A
Neurosci Lett; 2020 Feb; 720():134754. PubMed ID: 31945448
[TBL] [Abstract][Full Text] [Related]
11. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
[TBL] [Abstract][Full Text] [Related]
12. FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.
Santos M; Carvalho S; Lima L; Mota-Pereira J; Pimentel P; Maia D; Correia D; Gomes S; Cruz A; Medeiros R
J Affect Disord; 2015 Oct; 185():164-9. PubMed ID: 26186532
[TBL] [Abstract][Full Text] [Related]
13. FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder.
Ellsworth KA; Moon I; Eckloff BW; Fridley BL; Jenkins GD; Batzler A; Biernacka JM; Abo R; Brisbin A; Ji Y; Hebbring S; Wieben ED; Mrazek DA; Weinshilboum RM; Wang L
Pharmacogenet Genomics; 2013 Mar; 23(3):156-66. PubMed ID: 23324805
[TBL] [Abstract][Full Text] [Related]
14. A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping.
Fabbri C; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Uher R; Lewis CM; Serretti A
Transl Psychiatry; 2020 Feb; 10(1):50. PubMed ID: 32066715
[TBL] [Abstract][Full Text] [Related]
15. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
[TBL] [Abstract][Full Text] [Related]
16. Neuronal cell adhesion genes and antidepressant response in three independent samples.
Fabbri C; Crisafulli C; Gurwitz D; Stingl J; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Girolamo GD; Serretti A
Pharmacogenomics J; 2015 Dec; 15(6):538-48. PubMed ID: 25850031
[TBL] [Abstract][Full Text] [Related]
17. A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.
Zhang C; Li Z; Wu Z; Chen J; Wang Z; Peng D; Hong W; Yuan C; Wang Z; Yu S; Xu Y; Xu L; Xiao Z; Fang Y
Psychopharmacology (Berl); 2014 Feb; 231(4):685-93. PubMed ID: 24114429
[TBL] [Abstract][Full Text] [Related]
18. Rare copy number variation in treatment-resistant major depressive disorder.
O'Dushlaine C; Ripke S; Ruderfer DM; Hamilton SP; Fava M; Iosifescu DV; Kohane IS; Churchill SE; Castro VM; Clements CC; Blumenthal SR; Murphy SN; Smoller JW; Perlis RH
Biol Psychiatry; 2014 Oct; 76(7):536-41. PubMed ID: 24529801
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
Calati R; Crisafulli C; Balestri M; Serretti A; Spina E; Calabrò M; Sidoti A; Albani D; Massat I; Höfer P; Amital D; Juven-Wetzler A; Kasper S; Zohar J; Souery D; Montgomery S; Mendlewicz J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():271-8. PubMed ID: 23537502
[TBL] [Abstract][Full Text] [Related]
20. The role of the potassium channel gene KCNK2 in major depressive disorder.
Congiu C; Minelli A; Bonvicini C; Bortolomasi M; Sartori R; Maj C; Scassellati C; Maina G; Trabucchi L; Segala M; Gennarelli M
Psychiatry Res; 2015 Feb; 225(3):489-92. PubMed ID: 25535009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
